Arterial gene transfer of naked DNA for therapeutic angiogenesis: Early clinical results

Advanced Drug Delivery Reviews

Volumn 30, Issue 1-3, 1998, Pages 185-197

  Isner, Jeffrey M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Collateral vessels; Critical limb ischemia; Endothelium; Peripheral vascular disease; VEGF

Indexed keywords

ANGIOGRAPHY; BLOOD VESSELS; CELLS; DISEASES; DNA; DRUG DOSAGE; DRUG PRODUCTS; GENES; GENETIC ENGINEERING; HEMODYNAMICS; HORMONES; MEDICAL IMAGING;

ANGIOGENESIS; ARTERIAL GENE TRANSFER; COLLATERAL VESSELS; CONTRAST ANGIOGRAPHY; CRITICAL LIMB ISCHEMIA; ENDOTHELIUM; MAGNETIC RESONANCE ANGIOGRAPHY; PERIPHERAL VASCULAR DISEASE;

DRUG THERAPY;

PLASMID DNA; POLYMER; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE COURSE; DOPPLER FLOWMETRY; FEMALE; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN TISSUE; HYDROGEL; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVASCULAR ULTRASOUND; LIMB ISCHEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

EID: 0032473413     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00115-4     Document Type: Review

References (67)

1. Albers M., Fratezi A.C., DeLuccia N. Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease. J. Vasc. Surg. 16:1992;54-59.
2. J.A. Dormandy, P.R.S. Thomas, What is the natural history of a critically ischemic patient with and without his leg? in: R.M. Greenhalgh, C.W. Jamieson, A.N. Nicolaides (Eds.), Limb Salvage and Amputation for Vascular Disease, WB Saunders Co., Philadelphia, 1988, p. 11-26.
3. European Working Group on Critical Leg Ischemia, Second European consensus document on chronic critical leg ischemia, Circulation 84 (1991) IV-1-IV-26.
4. Isner J.M., Rosenfield K. Redefining the treatment of peripheral artery disease: Role of percutaneous revascularization. Circulation. 88:1993;1534-1557.
5. Pentecost M.J., Criqui M.H., Dorros G., Goldstone J., Johnston K.W., Martin E.C., Ring E.J., Spies J.B. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels: a statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. Circulation. 89:1994;511-531.
6. Folkman J., Merler E., Abernathy C., Williams G. Isolation of a tumor factor responsible for angiogenesis. J. Exp. Med. 133:1971;275-288.
7. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1971;1182-1186.
8. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann. Surg. 175:1972;409-416.
9. Banai S., Jaklitsch M.T., Casscells W., Shou M., Shrivastav S., Correa R., Epstein S.E., Unger E.F. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ. Res. 69:1991;76-85.
10. Baffour R., Danylewick R., Burdon T. An angiographic study of ischemia as a determinant of neovascularization in arteriovenous reversal. Surg. Gynecol. Obstet. 166:1988;28-32.
11. Yanagisawa-Miwa A., Uchida Y., Nakamura F., Tomaru T., Kido H., Kamijo T., Sugimoto T., Kaji K., Utsuyama M., Kurashima C., Ito H. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 257:1992;1401-1403.
12. Takeshita S., Zheng L.P., Brogi E., Kearney M., Pu L.Q., Bunting S., Ferrara N., Symes J.F., Isner J.M. Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J. Clin. Invest. 93:1994;662-670.
13. Banai S., Jaklitsch M.T., Shou M., Lazarous D.F., Scheinowitz M., Biro S., Epstein S.E., Unger E.F. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:1994;2183-2189.
14. Pearlman J.D., Hibberd M.G., Chuang M.L., Harada K., Lopez J.J., Gladston S.R., Friedman M., Sellke F.W., Simons M. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med. 1:1995;1085-1089.
15. Pu L.Q., Sniderman A.D., Brassard R., Lachapelle K.J., Graham A.M., Lisbona R., Symes J.F. Enhanced revascularization of the ischemic limb by means of angiogenic therapy. Circulation. 88:1993;208-215.
16. Höckel M., Schlenger K., Doctrow S., Kissel T., Vaupel P. Therapeutic angiogenesis. Arch. Surg. 128:1993;423-429.
17. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447.
18. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 267:1992;10931-10934.
19. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:1989;851-855.
20. Keck P.J., Hauser S.D., Krivi G., Sanzo K., Warren T., Feder J., Connolly D.T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 246:1989;1309-1312.
21. Plouet J., Schilling J., Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J. 8:1989;3801-3806.
22. D'Amore P.A., Thompson R.W. Mechanisms of angiogenesis. Annu. Rev. Physiol. 49:1987;453-464.
23. Folkman J., Haudenschild C. Angiogenesis in vitro. Nature. 288:1980;551-556.
24. Vernon R.B., Sage E.H. Between molecules and morphology. Extracellular matrix and creation of vascular form. Am. J. Pathol. 147:1995;873-883.
25. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-805.
26. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49:1983;327-333.
27. Pickering J.G., Weir L., Jekanowski J., Kearney M.A., Isner J.M. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J. Clin. Invest. 91:1993;1469-1480.
28. Tischer E., Mitchell R., Hartmann T., Silva M., Gospodarowicz D., Fiddes J., Abraham J. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:1991;11947-11954.
29. Takeshita S., Losordo D.W., Kearney M., Isner J.M. Time course of recombinant protein secretion following liposome-mediated gene transfer in a rabbit arterial organ culture model. Lab. Invest. 71:1994;387-391.
30. Losordo D.W., Pickering J.G., Takeshita S., Leclerc G., Gal D., Weir L., Kearney M., Jekanowski J., Isner J.M. Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo: Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation. 89:1994;785-792.
31. Riessen R., Rahimizadeh H., Blessing E., Takeshita S., Barry J.J., Isner J.M. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum. Gene Ther. 4:1993;749-758.
32. Pu L.Q., Sniderman A.D., Arekat Z., Graham A.M., Brassard R., Symes J.F. Angiogenic growth factor and revascularization of the ischemic limb: Evaluation in a rabbit model. J. Surg. Res. 54:1993;575-583.
33. Minutes Recombinant DNA Advisory Committee (RAC) of National Institutes of Health, Sept 13, 1994, RAC #9409-088 approved in final form 11/15/94.
34. S. Takeshita, L.P. Zheng, T. Asahara, R. Riessen, E. Brogi, N. Ferrara, J.F. Symes, J.M. Isner, In vivo evidence of enhanced angiogenesis following direct arterial gene transfer of the plasmid encoding vascular endothelial growth factor, Circulation 88 (1993) I-476 (Abstract).
35. S. Takeshita, C. Bauters, T. Asahara, L.P. Zheng, S.T., Rossow, M. Kearney, J.J. Barry, N. Ferrara, J.F. Symes, J.M. Isner, Physiologic assessment of angiogenesis by arterial gene therapy with vascular endothelial growth factor. Circulation 90 (1994) I-90 (Abstract).
36. Takeshita S., Tsurumi Y., Couffinhal T., Asahara T., Bauters C., Symes J.F., Ferrara N., Isner J.M. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 75:1996;487-502.
37. Guo Z.S., Wang L-H., Eisensmith R.C., Woo S.L.C. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Therapy. 3:1996;802-810.
38. K. Rosenfield, J.M. Isner, Intravascular ultrasound in patients undergoing coronary and peripheral arterial revascularization, in: E. Topol (Eds.), Interventional Cardiology, 2nd edn., W.B. Saunders, Philadelphia, 1993, p. 1153-1185.
39. Bauters C., Asahara T., Zheng L.P., Takeshita S., Bunting S., Ferrara N., Symes J.F., Isner J.M. Site-specific therapeutic angiogenesis following systemic administration of vascular endothelial growth factor. J. Vasc. Surg. 21:1995;314-325.
40. Brogi E., Schatteman G., Wu T., Kim E.A., Varticovski L., Keyt B., Isner J.M. Hypoxia-induced paracrine regulation of VEGF receptor expression. J. Clin. Invest. 97:1996;469-476.
41. Asahara T., Bauters C., Pastore C.J., Kearney M., Rossow S., Bunting S., Ferrara N., Symes J.F., Isner J.M. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 91:1995;2793-2801.
42. Bauters C., Asahara T., Zheng L.P., Takeshita S., Bunting S., Ferrara N., Symes J.F., Isner J.M. Physiologic assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 267:1994;H1263-H1271.
43. Knowles M.R., Hohneker K.W., Shou Z., Olsen J.C., Noah T.L., Hu P-C., Leigh M.W., Engelhardt J.F., Edwards L.J., Jones K.R., Grossman M., Wilson J.M., Johnson L.G., Boucher R.C. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333:1995;823-831.
44. Meddell J.R., Kissel J.T., Amato A.A., King W., Signore L., Prior T.W., Sahenk Z., Benson S., McAndrew P.E., Rice R., Nagaraja H., Stephens R., Lantry L., Morris G.E., Burghes A.H.M. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333:1995;832-838.
45. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
46. Lin H., Parmacek M.S., Morle G., Bolling S., Leiden J.M. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation. 82:1990;2217-2221.
47. Buttrick P.M., Kass A., Kitsis R.N., Kaplan M.L., Leinwand L.A. Behavior of genes directly injected into the rat heart in vivo. Circ. Res. 70:1992;193-198.
48. Chapman G.D., Lim C.S., Gammon R.S., Culp S.C., Desper J.S., Bauman R.P., Swain J.L., Stack R.S. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circ. Res. 71:1992;27-33.
49. Gal D., Weir L., Leclerc G., Pickering J.G., Hogan J., Isner J.M. Direct myocardial transfection in two animal models: Evaluation of parameters affecting gene expression and percutaneous gene delivery. Lab. Invest. 68:1993;18-25.
50. Conry R.M., LoBuglio A.F., Kantor J., Schlom J., Loechel F., Moore S.E., Sumerel L.A., Barlow D.L., Abrams S., Curiel D.T. Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res. 54:1994;1164-1168.
51. Ohno T., Gordon D., San H., Pompili V.J., Imperiale M.J., Nabel G.J., Nabel E.G. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 265:1994;781-784.
52. Schulick A.H., Newman K.D., Virmani R., Dichek D.A. In vivo gene transfer into injured carotid arteries: optimization and evaluation of acute toxicity. Circulation. 91:1995;2407-2414.
53. Chang M.W., Barr E., Jonathan S., Jiang Y.Q., Nabel G.J., Nabel E.G., Parmacek M.S., Leiden J.M. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 267:1995;518-522.
54. Zwiebel J., Freeman S., Kantoff P., Cornetta K., Ryan U., Anderson W. High-level of recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors. Science. 243:1989;220-243.
55. Mulligan R.C. The basic science of gene therapy. Science. 260:1993;926-932.
56. von der Leyen H.E., Leyen V.D., Gibbons G.H., Morishita R., Lewis N.P., Zhang L., Nakajima M., Kaneda Y., Coole J.P., Dzau V.J. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cellnitric oxide synthase gene. Proc. Natl. Acad. Sci. USA. 92:1995;137-1141.
57. Willard J.E., Landau C., Glamann B., Burns D., Jessen M.E., Pirwitz M.J., Gerard R.D., Meidell R.S. Genetic modification of the vessel wall: comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation. 89:1994;190-2197.
58. Guzman R.J., Hirschowitz E.A., Brody S.L., Crystal R.G., Epstein S.E., Finkel T. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA. 91:1994;0732-10736.
59. Grossman M., Raper S.E., Kozarsky K., Stein E.A., Engelhardt J.F., Muller D., Lupien P.J., Wilson J.M. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nature Genet. 6:1994;35-341.
60. Lemarchand P., Jones M., Yamada I., Crystal R.G. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ. Res. 72:1993;132-1138.
61. Riessen R., Isner J.M. Prospects for site-specific delivery of pharmacologic and molecular therapies. J. Am. Coll. Cardiol. 23:1994;234-1244.
62. White F.C., Carroll S.M., Magnet A., Bloor C.M. Coronary collateral development in swine after coronary artery occlusion. Circ. Res. 71:1992;490-1500.
63. Unger E.F., Banai S., Shou M., Lazarous D.F., Jaklitsch M.T., Scheinowitz M., Klingbeil C., Epstein S.E. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am. J. Physiol. 266:1994;1588-1595.
64. Takeshita S., Rossow S.T., Kearney M., Zheng L.P., Bauters C., Bunting S., Ferrara N., Symes J.F., Isner J.M. Time course of increased cellular proliferation in collateral arteries following administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am. J. Pathol. 147:1995;649-1660.
65. J. Horowitz, M. Hariawala, D.D. Sheriff, B. Keyt, J.F. Symes, In vivo administration of vascular endothelial growth factor is associated with EDRF-dependent systemic hypotension in porcine and rabbit animal models. Circulation 92 (1995) 630-I-631 (Abstract).
66. Ku D.D., Zaleski J.K., Liu S., Brock T.A. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265:1993;586-592.
67. 165. Lancet. 348:1996;70-374.